- Home
- PANL vs DCTH Comparison
PANL vs DCTH Comparison
Compare PANL & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANL
- DCTH
- Stock Information
- Founded
- PANL 1996
- DCTH 1988
- Country
- PANL United States
- DCTH United States
- Employees
- PANL N/A
- DCTH N/A
- Industry
- PANL Marine Transportation
- DCTH Medical/Dental Instruments
- Sector
- PANL Consumer Discretionary
- DCTH Health Care
- Exchange
- PANL Nasdaq
- DCTH Nasdaq
- Market Cap
- PANL 257.0M
- DCTH 352.0M
- IPO Year
- PANL N/A
- DCTH N/A
- Fundamental
- Price
- PANL $4.90
- DCTH $11.97
- Analyst Decision
- PANL Strong Buy
- DCTH Strong Buy
- Analyst Count
- PANL 1
- DCTH 4
- Target Price
- PANL N/A
- DCTH $21.50
- AVG Volume (30 Days)
- PANL 216.3K
- DCTH 345.3K
- Earning Date
- PANL 11-12-2024
- DCTH 11-08-2024
- Dividend Yield
- PANL 8.21%
- DCTH N/A
- EPS Growth
- PANL N/A
- DCTH N/A
- EPS
- PANL 0.47
- DCTH N/A
- Revenue
- PANL $521,238,386.00
- DCTH $22,644,000.00
- Revenue This Year
- PANL $8.04
- DCTH $1,605.13
- Revenue Next Year
- PANL $13.05
- DCTH $111.67
- P/E Ratio
- PANL $10.44
- DCTH N/A
- Revenue Growth
- PANL 5.23
- DCTH 945.91
- 52 Week Low
- PANL $4.82
- DCTH $3.70
- 52 Week High
- PANL $9.53
- DCTH $13.30
- Technical
- Relative Strength Index (RSI)
- PANL 30.46
- DCTH 51.68
- Support Level
- PANL $4.82
- DCTH $10.75
- Resistance Level
- PANL $5.05
- DCTH $11.59
- Average True Range (ATR)
- PANL 0.16
- DCTH 0.70
- MACD
- PANL -0.01
- DCTH -0.11
- Stochastic Oscillator
- PANL 14.81
- DCTH 24.56
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.